Bond.az White LogoBond.az Black Logo

Piper Sandler Lowers Figma Target on Margin

Piper Sandler cuts Figma price target to $30 from $35 due to margin pressure, despite strong revenue growth of 46% in Q1.

William Thomas
ByWilliam Thomas- Senior Editor
|
0

Piper Sandler lowered its price target on Figma Inc to $30 from $35, while maintaining an Overweight rating.

Figma's Q1 revenue grew 46% YoY, beating estimates by 5.5%. Net dollar retention hit 139%, the highest in over two years.

Q2 revenue growth guidance of 40% YoY is 9 percentage points above consensus. The company raised its FY2026 revenue growth midpoint to 35% from ~30%.

Q1 gross margins of 82.3% missed expectations, declining 3.8 percentage points QoQ due to higher inference costs. Operating margin guidance was raised to 9%.

Piper Sandler trimmed its target due to lower software multiples across the sector.

RBC Capital cut its target to $28, Oppenheimer reiterated a Perform rating.

More News
Today / 14:12
|
411

Forgent Stock Target Raised to $63 on Record Orders

TD Cowen raised Forgent Power Solutions stock price target to $63, citing record orders and strong financial results. The stock has gained 73% YTD.

0
Today / 14:12
|
626

Fiserv Price Target Cut on Execution Fears

TD Cowen slashes Fiserv price target to $64 on execution concerns. Get the latest analysis on Fiserv stock, AI initiatives, and future outlook.

0
Today / 14:11
|
778

TD Cowen raises Nvidia price target to $275 on AI demand

TD Cowen raises Nvidia price target to $275 on AI demand and strong fundamentals. Read more on Bond.az.

0
Today / 13:52
|
476

Piper Sandler cuts Boot Barn target on guidance

Piper Sandler lowered Boot Barn price target to $226 from $230, maintaining Overweight. Q4 results beat, FY2027 guidance implies EPS growth up to 18%. Stock down 17% YTD.

0
Today / 13:52
|
537

Piper Sandler Raises Charles Schwab Target to $105

Piper Sandler raises Charles Schwab price target to $105. Analyst cites revenue guidance boost from investor day.

0
Today / 13:50
|
209

Piper Sandler Raises Biogen Target to $225

Piper Sandler raises Biogen price target to $225 from $214. Phase II trial of BIIB080 missed primary endpoint but showed slowing of clinical decline at lowest dose.

0
Today / 13:44
|
314

Piper Sandler reiterates Boston Properties stock rating

Piper Sandler reaffirms Overweight rating on Boston Properties stock with $75 target. AI demand driving office market changes.

0
Today / 13:04
|
455

Benchmark Reiterates Hold on Dine Brands Stock

Benchmark reiterates Hold on Dine Brands Global shares after $100 million buyback plan. Stock up 9.3% last week.

0
Today / 13:03
|
202

Benchmark maintains Texas Roadhouse Hold rating

Benchmark maintains Texas Roadhouse Hold rating. Stock at $177.06, analyst targets $165-$234.

0
Today / 13:02
|
431

GEN Restaurant Group Hold maintained

Benchmark maintains Hold on GEN Restaurant Group after Q1 2026 results miss estimates on revenue and profit.

0
Today / 12:25
|
786

Orrstown Gets Neutral Rating from DA Davidson

DA Davidson gives Orrstown Financial a neutral rating with $41 target. Strong deposit base and 11-year dividend growth highlight the bank's stability.

0
Today / 12:23
|
659

DA Davidson Initiates Unity Bancorp with Buy Rating

DA Davidson initiates Unity Bancorp with buy rating and $68 target. Strong growth outlook and dividend history highlighted.

0
...
Piper Sandler Lowers Figma Target on Margin | Bond.az